The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Antimicrobial Peptide Resistance Mechanisms of Human Bacterial Pathogens
Open accessAbstract
The critical role played by antimicrobial peptides (AMPs) in mammalian innate immunity is increasingly recognized. Bacteria differ in their intrinsic susceptibility to AMPs, and the relative resistance of some important human pathogens to these defense molecules is now appreciated as an important virulence phenotype. Experimental analysis has identified diverse mechanisms of bacterial AMP resistance including altered cell surface charge, active efflux, production of proteases or trapping proteins, and modification of host cellular processes. The contribution of these resistance mechanisms to pathogenesis is confirmed through direct comparison of wild-type bacteria and AMP-sensitive mutants using in vivo infection models. Knowledge of the molecular basis of bacterial AMP resistance may provide new targets for antimicrobial therapy of human infectious diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract
Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nuñez, G., & Flavell, R. A. (2005) · Science · doi:10.1126/science.1104911 · Cited by 1,776
Innate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198
Self-citationHuman β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis
Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., & Wilson, J. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81895-4 · Cited by 1,080
Wilson, C. L., Ouellette, A. J., Satchell, D. P., Ayabe, T., López-Boado, Y. S., Stratman, J. L., Hultgren, S. J., Matrisian, L. M., & Parks, W. C. (1999) · Science · doi:10.1126/science.286.5437.113 · Cited by 1,074
Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid
Smith, J. J., Travis, S. M., Greenberg, E. P., & Welsh, M. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81099-5 · Cited by 1,039
Peschel, A., Otto, M., Jack, R. W., Kalbacher, H., Jung, G., & Götz, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8405 · Cited by 994
Angiogenins: a new class of microbicidal proteins involved in innate immunity
Hooper, L. V., Stappenbeck, T. S., Hong, C. V., & Gordon, J. I. (2003) · Nature Immunology · doi:10.1038/ni888 · Cited by 929
Peschel, A., Jack, R. W., Otto, M., Collins, L. V., Staubitz, P., Nicholson, G., Kalbacher, H., Nieuwenhuizen, W. F., Jung, G., Tarkowski, A., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1067 · Cited by 786
Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin
Salzman, N. H., Ghosh, D., Huttner, K. M., Paterson, Y., & Bevins, C. L. (2003) · Nature · doi:10.1038/nature01520 · Cited by 765
Bals, R., Wang, X., Zasloff, M., & Wilson, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9541 · Cited by 746
Lipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides
Guo, L., Lim, K. B., Poduje, C. M., Daniel, M., Gunn, J. S., Hackett, M., & Miller, S. I. (1998) · Cell · doi:10.1016/s0092-8674(00)81750-x · Cited by 649
Dunman, P. M., Murphy, E., Haney, S., Palacios, D., Tucker-Kellogg, G., Wu, S., Brown, E. L., Zagursky, R. J., Shlaes, D., & Projan, S. J. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.24.7341-7353.2001 · Cited by 648
Naser, S. A., Ghobrial, G., Romero, C., & Valentine, J. F. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17058-x · Cited by 626
Oren, Z., Lerman, J. C., Gudmundsson, G. H., Agerberth, B., & Shai, Y. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3410501 · Cited by 599
Heilborn, J. D., Nilsson, M. F., Sørensen, O., Ståhle-Bäckdahl, M., Kratz, G., Weber, G., & Borregaard, N. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12069.x · Cited by 572
Dorschner, R. A., Pestonjamasp, V. K., Tamakuwala, S., Ohtake, T., Rudisill, J., Nizet, V., Agerberth, B., Gudmundsson, G. H., & Gallo, R. L. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01340.x · Cited by 567
Self-citationBoman, H. G., Agerberth, B., & Boman, A. (1993) · Infection and Immunity · doi:10.1128/iai.61.7.2978-2984.1993 · Cited by 551
Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus -Derived Proteinases
Sieprawska-Lupa, M., Mydel, P., Krawczyk, K., Wójcik, K., Puklo, M., Lupa, B., Suder, P., Silberring, J., Reed, M., Pohl, J., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4673-4679.2004 · Cited by 551
Capsule Polysaccharide Mediates Bacterial Resistance to Antimicrobial Peptides
Campos, M. A., Vargas, M. A., Regueiro, V., Llompart, C. M., Albertí, S., & Bengoechea, J. A. (2004) · Infection and Immunity · doi:10.1128/iai.72.12.7107-7114.2004 · Cited by 518
Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study
Pütsep, K., Carlsson, G., Boman, H. G., & Andersson, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11201-3 · Cited by 499
Specific Lipopolysaccharide Found in Cystic Fibrosis Airway Pseudomonas aeruginosa
Ernst, R. K., Yi, E. C., Guo, L., Lim, K. B., Burns, J. L., Hackett, M., & Miller, S. I. (1999) · Science · doi:10.1126/science.286.5444.1561 · Cited by 484
How do bacteria resist human antimicrobial peptides?
Peschel, A. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02333-8 · Cited by 465
McPhee, J. B., Lewenza, S., & Hancock, R. E. W. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03673.x · Cited by 443
Landers, C. J., Cohavy, O., Misra, R., Yang, H., Lin, Y., Braun, J., & Targan, S. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.35379 · Cited by 440
Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL‐37
Schmidtchen, A., Frick, I., Andersson, E., Tapper, H., & Björck, L. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03146.x · Cited by 439
Islam, D., Bandholtz, L., Nilsson, J., Wigzell, H., Christensson, B., Agerberth, B., & Gudmundsson, G. H. (2001) · Nature Medicine · doi:10.1038/84627 · Cited by 429
Moskowitz, S. M., Ernst, R. K., & Miller, S. I. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.2.575-579.2004 · Cited by 418
Di Nardo, A., Vitiello, A., & Gallo, R. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2274 · Cited by 405
Active efflux, a common mechanism for biocide and antibiotic resistance
Levy, S. B. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.4.x · Cited by 401
Gunn, J. S., Ryan, S. S., van Velkinburgh, J. C., Ernst, R. K., & Miller, S. I. (2000) · Infection and Immunity · doi:10.1128/.68.11.6139-6146.2000 · Cited by 398
Shafer, W. M., Qu, X.-D., Waring, A. J., & Lehrer, R. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1829 · Cited by 391
Guina, T., Yi, E. C., Wang, H., Hackett, M., & Miller, S. I. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.14.4077-4086.2000 · Cited by 322
Jin, T., Bokarewa, M., Foster, T., Mitchell, J., Higgins, J., & Tarkowski, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1169 · Cited by 319
Abachin, E., Poyart, C., Pellegrini, E., Milohanic, E., Fiedler, F., Berche, P., & Trieu‐Cuot, P. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02723.x · Cited by 315
Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides
Bader, M. W., Navarre, W. W., Shiau, W., Nikaido, H., Frye, J. G., McClelland, M., Fang, F. C., & Miller, S. I. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03675.x · Cited by 260
Rosenberger, C. M., Gallo, R. L., & Finlay, B. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304455101 · Cited by 244
Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence
Park, P. W., Pier, G. B., Hinkes, M. T., & Bernfield, M. (2001) · Nature · doi:10.1038/35075100 · Cited by 243
outer membrane remodeling: role in resistance to host innate immunity
Ernst, R. K., Guina, T., & Miller, S. I. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01494-0 · Cited by 238
Iimura, M., Gallo, R. L., Hase, K., Miyamoto, Y., Eckmann, L., & Kagnoff, M. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4901 · Cited by 236
Inactivation of Human β-Defensins 2 and 3 by Elastolytic Cathepsins
Taggart, C. C., Greene, C. M., Smith, S. G., Levine, R. L., McCray, P. B., O’Neill, S., & McElvaney, N. G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.931 · Cited by 226
β-Defensin 1 Contributes to Pulmonary Innate Immunity in Mice
Moser, C., Weiner, D. J., Lysenko, E., Bals, R., Weiser, J. N., & Wilson, J. M. (2002) · Infection and Immunity · doi:10.1128/iai.70.6.3068-3072.2002 · Cited by 213
Characterization of the Mouse Beta Defensin 1, Defb1 , Mutant Mouse Model
Morrison, G., Kilanowski, F., Davidson, D., & Dorin, J. (2002) · Infection and Immunity · doi:10.1128/iai.70.6.3053-3060.2002 · Cited by 212
Jerse, A. E., Sharma, N. D., Simms, A. N., Crow, E. T., Snyder, L. A., & Shafer, W. M. (2003) · Infection and Immunity · doi:10.1128/iai.71.10.5576-5582.2003 · Cited by 209
Macfarlane, E. L. A., Kwasnicka, A., & Hancock, R. E. W. (2000) · Microbiology · doi:10.1099/00221287-146-10-2543 · Cited by 209
Group A streptococci in the 1990s
Efstratiou, A. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.suppl_1.3 · Cited by 195
Antibody-enhanced pneumococcal adherence requires IgA1 protease
Weiser, J. N., Bae, D., Fasching, C., Scamurra, R. W., Ratner, A. J., & Janoff, E. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0637469100 · Cited by 193
SIC, a Secreted Protein of Streptococcus pyogenesThat Inactivates Antibacterial Peptides
Frick, I.-M., Åkesson, P., Rasmussen, M., Schmidtchen, A., & Björck, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301995200 · Cited by 193
Gao, L., Laval, F., Lawson, E. H., Groger, R. K., Woodruff, A., Morisaki, J. H., Cox, J. S., Daffe, M., & Brown, E. J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03667.x · Cited by 193
Bacterial modification of LPS and resistance to antimicrobial peptides
Gunn, J. S. (2001) · Journal of Endotoxin Research · doi:10.1177/09680519010070011001 · Cited by 191
Lysenko, E. S., Gould, J., Bals, R., Wilson, J. M., & Weiser, J. N. (2000) · Infection and Immunity · doi:10.1128/iai.68.3.1664-1671.2000 · Cited by 181
Ernst, R. K., Guina, T., & Miller, S. I. (1999) · The Journal of Infectious Diseases · doi:10.1086/513850 · Cited by 179
Liu, L., Roberts, A. A., & Ganz, T. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.575 · Cited by 178
Birchler, T., Seibl, R., Büchner, K., Loeliger, S., Seger, R., Hossle, J. P., Aguzzi, A., & Lauener, R. P. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200111)31:11<3131::aid-immu3131>3.0.co;2-g · Cited by 176
Veal, W. L., Nicholas, R. A., & Shafer, W. M. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.20.5619-5624.2002 · Cited by 176
Staubitz, P., Neumann, H., Schneider, T., Wiedemann, I., & Peschel, A. (2004) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00921-2 · Cited by 171
Cathelicidin family of antimicrobial peptides: Proteolytic processing and protease resistance
Shinnar, A. E., Butler, K. L., & Park, H. J. (2003) · Bioorganic Chemistry · doi:10.1016/s0045-2068(03)00080-4 · Cited by 170
Poyart, C., Pellegrini, E., Marceau, M., Baptista, M., Jaubert, F., Lamy, M., & Trieu‐Cuot, P. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03655.x · Cited by 165
Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease
Wehkamp, J., Schmid, M., Fellermann, K., & Stange, E. F. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904543 · Cited by 164
Syndecan-1 Shedding Is Enhanced by LasA, a Secreted Virulence Factor of Pseudomonas aeruginosa
Park, P. W., Pier, G. B., Preston, M. J., Goldberger, O., Fitzgerald, M. L., & Bernfield, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3057 · Cited by 160
Schmidtchen, A., Frick, I., & Björck, L. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02251.x · Cited by 160
Detweiler, C. S., Monack, D. M., Brodsky, I. E., Mathew, H., & Falkow, S. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03455.x · Cited by 159
Cao, M., & Helmann, J. D. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.4.1136-1146.2004 · Cited by 158
Nishi, H., Komatsuzawa, H., Fujiwara, T., Holmes, N., & Sugai, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4800-4807.2004 · Cited by 151
Hidalgo‐Grass, C., Dan‐Goor, M., Maly, A., Eran, Y., Kwinn, L. A., Nizet, V., Ravins, M., Jaffe, J., PEYSER, A. B., Moses, A. E., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15643-2 · Cited by 144
Parra-Lopez, C., Lin, R., Aspedon, A., & Groisman, E. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06712.x · Cited by 134
Lee, P. H. A., Ohtake, T., Zaiou, M., Murakami, M., Rudisill, J. A., Lin, K. H., & Gallo, R. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500268102 · Cited by 130
Identification of Proteus mirabilis Mutants with Increased Sensitivity to Antimicrobial Peptides
McCoy, A. J., Liu, H., Falla, T. J., & Gunn, J. S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2030-2037.2001 · Cited by 128
Kristian, S. A., Dürr, M. C., van Strijp, J. A. G., Neumeister, B., & Peschel, A. (2002) · Infection and Immunity · doi:10.1128/iai.71.1.546-549.2003 · Cited by 122
Kristian, S. A., Lauth, X., Nizet, V., Goetz, F., Neumeister, B., Peschel, A., & Landmann, R. M. (2003) · The Journal of Infectious Diseases · doi:10.1086/376533 · Cited by 120
Robey, M., O'Connell, W. A., & Cianciotto, N. P. (2001) · Infection and Immunity · doi:10.1128/iai.69.7.4276-4286.2001 · Cited by 120
Wu, H. J., Zhang, G., Minton, J. E., Ross, C. R., & Blecha, F. (2000) · Infection and Immunity · doi:10.1128/iai.68.10.5552-5558.2000 · Cited by 111
The role of the PhoP/PhoQ regulon in Salmonella virulence
Véscovi, E. G., Soncini, F. C., & Groisman, E. A. (1994) · Research in Microbiology · doi:10.1016/0923-2508(94)90096-5 · Cited by 105
Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin
Peschel, A., & Collins, L. V. (2001) · Peptides · doi:10.1016/s0196-9781(01)00500-9 · Cited by 105
Airway epithelia regulate expression of human β‐defensin 2 through toll‐like receptor 2
Wang, X., Zhang, Z., Louboutin, J., Moser, C., Weiner, D. J., & Wilson, J. M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0616fje · Cited by 98
Mason, K. M., Munson, R. S., & Bakaletz, L. O. (2004) · Infection and Immunity · doi:10.1128/iai.73.1.599-608.2005 · Cited by 95
Brogden, K. A., Kalfa, V. C., Ackermann, M. R., Palmquist, D. E., McCray, P. B., & Tack, B. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.331-334.2001 · Cited by 95
mig - 14 Is a Salmonella Gene That Plays a Role in Bacterial Resistance to Antimicrobial Peptides
Brodsky, I. E., Ernst, R. K., Miller, S. I., & Falkow, S. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.12.3203-3213.2002 · Cited by 91
Brodsky, I. E., Ghori, N., Falkow, S., & Monack, D. M. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04444.x · Cited by 88
Kupferwasser, L. I., Skurray, R. A., Brown, M. H., Firth, N., Yeaman, M. R., & Bayer, A. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2395 · Cited by 85
Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
Hill, H. R., Bohnsack, J. F., Morris, E. Z., Augustine, N. H., Parker, C. J., Cleary, P. P., & Wu, J. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.10.3551 · Cited by 83
DINULOS, J. G. H., Mentele, L., Fredericks, L. P., Dale, B. A., & Darmstadt, G. L. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.1.161-166.2003 · Cited by 82
Crouch, M. V., Becker, L. A., Bang, I. S., Tanabe, H., Ouellette, A. J., & Fang, F. C. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04578.x · Cited by 80
Starner, T. D., Swords, W. E., Apicella, M. A., & McCray, P. B. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.5287-5289.2002 · Cited by 74
West, N. P., Jungnitz, H., Fitter, J. T., et al. (2000) · Infection and Immunity · doi:10.1128/iai.68.8.4673-4680.2000 · Cited by 72
Probiotics — Role in inflammatory bowel disease
Gionchetti, P., Amadini, C., Rizzello, F., Venturi, A., Palmonari, V., Morselli, C., Romagnoli, R., & Campieri, M. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80166-9 · Cited by 60
Interaction of CAP18-Derived Peptides with Membranes Made from Endotoxins or Phospholipids
Gutsmann, T., Hagge, S. O., Larrick, J. W., Seydel, U., & Wiese, A. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)76259-5 · Cited by 60
DeVine, D., Marsh, P. D., Percival, R. S., Rangarajan, M., & Curtis, M. A. (1999) · Microbiology · doi:10.1099/13500872-145-4-965 · Cited by 59
Molecular analysis of efflux pump-based antibiotic resistance
Zgurskaya, H. I. (2002) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00195 · Cited by 52
Susceptibility ofListeria monocytogenesto antimicrobial peptides
López‐Solanilla, E., González‐Zorn, B., Novella, S., Vázquez-Boland, J. A., & Rodríguez‐Palenzuela, P. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00579-2 · Cited by 49
Improvement in Burn Wound Infection and Survival with Antimicrobial Peptide D2A21 (Demegel)
Chalekson, C. P., Neumeister, M. W., & Jaynes, J. M. (2002) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-200204010-00020 · Cited by 41
Induction of β-Defensin Resistance in the Oral AnaerobePorphyromonas gingivalis
Shelburne, C. E., Coulter, W. A., Olguin, D., Lantz, M. S., & Lopatin, D. E. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.183-187.2005 · Cited by 38
Tomasinsig, L., Scocchi, M., Loreto, C. D., Artico, D., & Zanetti, M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.5.1003 · Cited by 37
ENDOGENOUS ANTIMICROBIAL PEPTIDES AND SKIN INFECTIONS IN ATOPIC DERMATITIS
Wood, R. A. (2003) · PEDIATRICS · doi:10.1542/peds.112.s2.461a · Cited by 32
Lushbaugh, W. B., Blossom, A. C., Shah, P. H., Banga, A. K., Jaynes, J. M., Cleary, J. D., & Finley, R. W. (2000) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2000.63.284 · Cited by 25
Marceau, M., Sebbane, F., Collyn, F., & Simonet, M. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-48416-1_49 · Cited by 6
Cited by
Designing antimicrobial peptides: form follows function
Fjell, C. D., Hiss, J. A., Hancock, R. E. W., & Schneider, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3591 · Cited by 2,035
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
MARR, A., GOODERHAM, W., & HANCOCK, R. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.006 · Cited by 1,051
Antimicrobial peptides: key components of the innate immune system
Pasupuleti, M., Schmidtchen, A., & Malmsten, M. (2012) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2011.594423 · Cited by 799
Mechanisms and consequences of bacterial resistance to antimicrobial peptides
Andersson, D. I., Hughes, D., & Kubicek-Sutherland, J. Z. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.04.002 · Cited by 715
Multifunctional cationic host defence peptides and their clinical applications
Yeung, A. T. Y., Gellatly, S. L., & Hancock, R. E. W. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0710-x · Cited by 610
Metadata
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.